Neuroendocrine Differentiation in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

BACKGROUND: Small cell lung cancer (SCLC) transformation during epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treatment in lung cancer has been suggested as one of possible resistance mechanisms. METHODS: We evaluated whether SCLC transformation or neuroendocrine (NE) differe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Youjin, Kim, Seon Ye, Choi, Yun Jung, So, Kwang Sup, Rho, Jin Kyung, Kim, Woo Sung, Lee, Jae Cheol, Chung, Jin-Haeng, Choi, Chang-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790027/
https://www.ncbi.nlm.nih.gov/pubmed/24101933
http://dx.doi.org/10.4046/trd.2013.75.3.95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790027/
https://www.ncbi.nlm.nih.gov/pubmed/24101933
http://dx.doi.org/10.4046/trd.2013.75.3.95

Ejemplares similares